Korean J Obstet Gynecol.  2001 Jul;44(7):1281-1284.

A Clinical, Pathologic and Prognostic Features of Adnexal Masses Operated on during Pregnancy

Affiliations
  • 1Department of Obstetrics & Gynecology, Masan Samsung Hospital College of Medicine, SungKyunKwan University, Masan, Korea.

Abstract


OBJECTIVE
The purpose of this study was to evaluate retrospective data concerning patients with adnexal masses that were managed surgically during pregnancy and their effect on fetal outcome.
METHODS
Data were reviewed concerning pregnant women who required surgery at our hospital from January 1991 to December 2000 for an adnexal mass.
RESULTS
In the recent 10 years at our hospital a total of 47 pregnant women aged 27.9+/-3.6 years were diagnosed with adnexal masses that required surgery. The masses were removed at 12.3+/-3.7 weeks of gestation and maximum diameter was 8.4+/-2.3 cm. The pathologic features of the 47 lesions were as follows : 17 mature cystic teratomas, 14 epithelial origins (12 serous cystadenoma, 2 mucinous cystadenoma), 9 functional cysts, 4 endometriotic cysts, 2 paraovarian cysts, 1 malignant neoplasm. Of the 41 patients for whom the outcome of pregnancy was available, 2 (4.2%) gave preterm birth before 37 weeks, while 4 (8.5%) experienced spontaneous abortion. There were not any perinatal death for the 43 infants.
CONCLUSION
Although our studies are smaller for confirmation, so larger studies are required, but our
results
suggest that an adnexal mass may be associated with an adverse fetal outcome. Surgical intervention at<22 weeks of gestation might not have been related to the adverse fetal outcomes.

Keyword

Pregnancy; Adnexal mass; Fetal outcome

MeSH Terms

Abortion, Spontaneous
Cystadenoma, Serous
Female
Humans
Infant
Mucins
Pregnancy*
Pregnant Women
Premature Birth
Retrospective Studies
Teratoma
Mucins
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr